Inhibitors of angiotensin-converting enzyme for treatment of hypertension (Q40121097)

17 September 2017

1 reference

title

Inhibitors of angiotensin-converting enzyme for treatment of hypertension (English)

1 reference

17 September 2017

main subject

arterial hypertension

0 references

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

6 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

6 September 2023

author name string

D. W. Cushman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6249323

6 September 2023

M. A. Ondetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6249323

6 September 2023

language of work or name

English

0 references

publication date

1 July 1980

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0006295280900969?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

https://api.elsevier.com/content/article/PII:0006295280900969?httpAccept=text/plain

6 September 2023

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

6 September 2023

published in

Biochemical Pharmacology

1 reference

17 September 2017

volume

29

1 reference

17 September 2017

issue

13

1 reference

17 September 2017

page(s)

1871-1877

1 reference

The existence of two forms of hypertensin

17 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

6 September 2023

3

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Isolation of bradykinin-potentiating peptides from Bothrops jararaca venom

6 September 2023

4

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis

6 September 2023

5

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

6 September 2023

6

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Design of potent competitive inhibitors of angiotensin-converting enzyme. Carboxyalkanoyl and mercaptoalkanoyl amino acids

6 September 2023

7

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung

6 September 2023

9

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Studies on the angiotensin converting enzyme with different substrates

6 September 2023

10

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Inhibition of homogeneous angiotensin-converting enzyme of rabbit lung by synthetic venom peptides of Bothrops jararaca

6 September 2023

11

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Captopril (SQ 14,225) (d-3-mercapto-2-methylpropanoyl-l-proline): A novel orally active inhibitor of angiotensin-converting enzyme and antihypertensive agent

6 September 2023

14

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Renin in rats with spontaneous hypertension

6 September 2023

16

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Chronic antihypertensive effects of captopril (SQ 14,225), an orally active angiotensin I-converting enzyme inhibitor, in conscious 2-kidney renal hypertensive rats

6 September 2023

19

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Effects of chronic treatment with captopril (SQ 14,225), an orally active inhibitor of angiotensin I-converting enzyme, in spontaneously hypertensive rats

6 September 2023

21

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

6 September 2023

22

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

6 September 2023

23

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive Patients

6 September 2023

27

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients

6 September 2023

28

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Hypotension induced by inhibition of angiotensin-converting enzyme in pentobarbital-anesthetized dogs

6 September 2023

29

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

6 September 2023

34

20

213

Wong

1978

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

CAPTOPRIL IN THE TREATMENT OF CLINICAL HYPERTENSION AND CARDIAC FAILURE

6 September 2023

36

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension

6 September 2023

37

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man

6 September 2023

38

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Inhibitors of the renin-angiotensin system in experimental hypertension, with a note on the measurement of angiotensin I, II and III during infusion of converting-enzyme inhibitor

6 September 2023

39

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation

6 September 2023

40

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Release of a Prostaglandin E-Like Substance from Canine Kidney by Bradykinin

6 September 2023

41

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

Autonomic neural influences on the dysrhythmias resulting from myocardial infarction

6 September 2023

42

1 reference

https://api.crossref.org/works/10.1016/0006-2952(80)90096-9

6 September 2023

Identifiers

1 reference

17 September 2017

1 reference